BROWSE·page 485 of 608

Browse EX-10 agreements

7,292 matching material contract exhibits.


FORM OF INDEMNITY AGREEMENT

Rank One Computing Corp

INDEMNITY AGREEMENT

 

This Indemnity Agreement (this “Agreement”) dated as of                  , is made by and between Rank One Computing Corporation, a Colorado corporation (the “Company”), and                  (“Indemnitee”). This Agreement shall be deemed to have taken effect as of the date that Indemnitee first became a director, officer, employee or agent of the Company.

 

Recitals

 

A. The Company desires to attract and retain the services of highly qualified individuals as directors, officers, employees and agents.

…

EX-10.1·8-K·CIK 2077709·ACC 0001213900-26-069062·Filed Jun 16, 2026, 08:57 ET

EXHIBIT 10.1

PALVELLA THERAPEUTICS, INC.

AMENDMENT NO. 1 TO THE PALVELLA THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN 

WHEREAS, Palvella Therapeutics, Inc. (the “Company”) maintains the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan (the “Plan”), which was previously adopted by the Board of Directors of the Company (the “Board”) and approved by the Company’s stockholders;

 

WHEREAS, the Board believes that the number of Shares (as defined in the Plan) remaining available for issuance under the Plan has become insufficient for the Company’s anticipated future needs under the Plan;

 

WHEREAS, the Board has determined that it is advisable and in the best interest of the Company and its stockholders to amend the Plan to increase the aggregate number of Shares reserved for issuance thereunder by 750,000 shares; and

 

WHEREAS, Section 11 of the Plan provides that the Board may amend the Plan at any time, subject to certain conditions set forth therein.

 

NOW, THEREFORE:

 

Section 3(a) of the Plan is hereby deleted it in its entirety and replaced with the following:

…

EX-10.1·8-K·CIK 1583648·ACC 0001104659-26-074338·Filed Jun 16, 2026, 08:30 ET

EX-10.1

Our Bond, Inc.

EXCHANGE AGREEMENT

This Exchange Agreement (this “Agreement”) is dated as of June 11, 2026, between Our Bond, Inc. (the “Company” or “Our Bond”) and the holder identified on the signature page hereto (the “Holder”).

 

WHEREAS, the Holder beneficially owns and holds the following promissory notes of the Company: (i) a promissory note issued March 1, 2025 in the original principal amount of $2,500,000, with a current balance of $2,292,179.85 (the “March Note”); and (ii) a promissory note issued May 4, 2026 in the original principal amount of $1,000,000, with a current balance of $1,010,277.78 (the “May Note”) (collectively, the “Original Notes”) which are currently due and owing, including all accrued and unpaid interest thereon through the Closing Date (as defined below), and have an aggregate current value of $3,302,457.63;

…

EX-10.1·8-K·CIK 1756064·ACC 0001493152-26-028818·Filed Jun 16, 2026, 08:17 ET

EX-10.3

Our Bond, Inc.

WAIVER and TWENTy-EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

THIS WAIVER AND TWENTY-EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is entered into as of June 11, 2026, by and between EASTWARD FUND MANAGEMENT, LLC, a Delaware limited liability company (“Lender”), and OUR BOND, INC., a Nevada corporation (successor-by-conversion and name change to TG-17, INC., a Delaware corporation) (“Borrower”).

 

Recitals

…

EX-10.3·8-K·CIK 1756064·ACC 0001493152-26-028818·Filed Jun 16, 2026, 08:17 ET

EX-10.2

Our Bond, Inc.

19505 Biscayne Blvd. ● Suite 2350 ● Aventura, FL 33180 ● legal@ascentpartnersllc.com

 

To:

Our Bond, Inc.

 

18 West 18th Street, 6th Floor

 

New York, NY 10011

 

Email: Doron.Kempel@ourbond.com

 

Attention:

Doron Kempel

 

Chief Executive Officer

 

June 11, 2026

 

Re: Amendment to Warrants to Purchase Common Stock

 

Dear Mr. Kempel:

 

Reference is made to (i) the Warrant to Purchase Common Stock dated October 27, 2025, under which Ascent Partners Fund LLC, a Delaware limited liability company (the “Purchaser”) may purchase up to 3,000,000 shares of common stock of Our Bond, Inc., a Nevada corporation (together with its successors and permitted assigns, the “Company”) at an exercise price of $12.35 for a period of sixteen (16) months from the date of issuance (the “16 Month Warrants”), and (ii) the Warrant to Purchase Common Stock dated October 27, 2025, under which the Purchaser may purchase up to 6,000,000 shares of common stock of the Company at an exercise price of $12.35 for a period of twenty-four (24) months from the date of issuance (th

…

EX-10.2·8-K·CIK 1756064·ACC 0001493152-26-028818·Filed Jun 16, 2026, 08:17 ET

EX-10.1

F&G Annuities & Life, Inc.

bluntemploymentagr06-30x


 


 


 


 


 


 


 


 


 


 


 


EX-10.1·8-K·CIK 1934850·ACC 0001934850-26-000061·Filed Jun 16, 2026, 07:03 ET

EX-10.2

F&G Annuities & Life, Inc.

murphyemploymentagramend


 


 


 


EX-10.2·8-K·CIK 1934850·ACC 0001934850-26-000061·Filed Jun 16, 2026, 07:03 ET

EX-10.3

F&G Annuities & Life, Inc.

baileyemploymentagr08-03


 


 


 


 


 


 


 


 


 


 


 


EX-10.3·8-K·CIK 1934850·ACC 0001934850-26-000061·Filed Jun 16, 2026, 07:03 ET

EX-10.1

SPACE EXPLORATION TECHNOLOGIES CORP

Document

Exhibit 10.1

AGREEMENT AND PLAN OF MERGER

dated as of

June 16, 2026

by and among

SPACE EXPLORATION TECHNOLOGIES CORP.,

X67 INC.,

and

ANYSPHERE, INC.


TABLE OF CONTENTS

ARTICLE 1 DEFINITIONS

2

Section 1.01

Definitions

2

Section 1.02

Other Definitional and Interpretative Provisions

18

ARTICLE 2 THE MERGER

18

Section 2.01

The Merger

18

Section 2.02

Conversion of Shares

19

Section 2.03

Surrender and Payment

20

Section 2.04

Treatment of Company

22

Section 2.05

Adjustments

23

Section 2.06

Fractional Shares

24

Section 2.07

Withholding Rights

24

Section 2.08

Lost Certificates

24

Section 2.09

Dissenting Shares

25

Section 2.10

Closing Deliveries

25

ARTICLE 3 THE SURVIVING CORPORATION

26

Section 3.01

Certificate of Incorporation

26

Section 3.02

Bylaws

26

Section 3.03

Directors and Officers

26

ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY

26

Section 4.01

Corporate Existence and Power

26

Section 4.02

Corporate Authorization

27

Section 4.03

Governmental Authorization

27

Section 4.04

…

EX-10.1·8-K·CIK 1181412·ACC 0001628280-26-043411·Filed Jun 16, 2026, 06:30 ET

EX-10.1

ENCORE CAPITAL GROUP INC

Document

Exhibit 10.1

AMENDED AND RESTATED ENCORE CAPITAL GROUP, INC.

2017 INCENTIVE AWARD PLAN

1.Purpose.

    The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities. The Plan amends and restates in its entirety the Encore Capital Group, Inc. 2017 Incentive Award Plan (the “Original Plan”). Capitalized terms used in the Plan are defined in Section 11.

2.Eligibility.

    Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein.

3.Administration and Delegation.

…

EX-10.1·8-K·CIK 1084961·ACC 0001084961-26-000050·Filed Jun 15, 2026, 20:40 ET

EX-10.1

Vivos Therapeutics, Inc.

COLLABORATION AGREEMENT

 

This Collaboration Agreement (this “Agreement”) is entered into as of June 9, 2026 (the “Effective Date”), by and between Vivos Therapeutics, Inc., a Delaware corporation with principal offices at 7921 Southpark Plaza, Suite 210, Littleton, CO 80120 (“Vivos”) and South Palm Cardiovascular Associates, LLC, a Florida limited liability company, with principal offices at 2300 S. Congress Ave, Suite 105 Boynton Beach, FL 33426 (“SPCVA” and, together with Vivos, the “Parties” and each individually a “Party”).

 

RECITALS

 

WHEREAS, Vivos is a medical technology company focused on the development and commercialization of innovative treatments and diagnostics for sleep-disordered breathing, including obstructive sleep apnea (“OSA”), among other related health conditions, and operates a network of provider-facing management services organizations and clinical support platforms;

…

EX-10.1·8-K·CIK 1716166·ACC 0001493152-26-028775·Filed Jun 15, 2026, 19:44 ET

SANDRIDGE ENERGY, INC.

 

 

 

2016 OMNIBUS INCENTIVE PLAN

(As Amended by the First Amendment)

 

 

 

ARTICLE I

PURPOSE

 

The purpose of this SandRidge Energy, Inc. 2016 Omnibus Incentive Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer Eligible Individuals cash and stock-based incentives in order to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company’s stockholders. The Plan is effective as of the date set forth in Article XIV.

 

ARTICLE II

DEFINITIONS

 

For purposes of the Plan, the following terms shall have the following meanings:

…

EX-10.1·8-K·CIK 1349436·ACC 0001213900-26-068945·Filed Jun 15, 2026, 18:14 ET